Current cell therapy strategies for repairing the central nervous system;Réparation du système nerveux central: Les stratégies actuelles de thérapie cellulaire

Revue Neurologique

Volumn 163, Issue HS1, 2007, Pages

  Feron F ^a  

^a Mediterranée University   (France)

Author keywords

Cell therapy; Ensheating cells; Immune cells; Neurodegenerative diseases; Spinal cord injury; Stem cells

Indexed keywords

IMMUNOMODULATING AGENT;

CELL DIFFERENTIATION; CELL THERAPY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DEGENERATIVE DISEASE; DISEASE COURSE; ENCEPHALITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUNTINGTON CHOREA; MACROPHAGE ACTIVATION; MEDICAL ETHICS; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL TRANSPLANTATION; NEUROBLAST; NEUROPROTECTION; NEUROTOXICITY; OLFACTORY ENSHEATHING CELL; PARKINSON DISEASE; PLURIPOTENT STEM CELL; T LYMPHOCYTE; TREATMENT OUTCOME; VACCINATION; WOUND HEALING;

EID: 34948841958     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)92156-6     Document Type: Conference Paper

References (82)

1. AKIYAMA Y, RADTKE C, HOUNMOU O, et al. (2002). Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia, 39: 229-236.
2. BACHOUD-LEVI AC, GAURA V, BRUGIÈ RES P, et al. (2006). Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol, 5: 303-309.
3. BACHOUD-LEVI AC, REMY P, NGUYEN JP, et al. (2000). Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet, 356: 1975-1979.
4. BARNETT SC, ALEXANDER CL, IWASHITA Y, et al. (2000). Identification of a human olfactory ensheathing cell that can effect transplantmediated remyelination of demyelinated CNS axons. Brain, 123: 1581-1588.
5. BECKER DB, JENSEN JN, MYCKATYN TM, et al. (2000). Effects of FKBP-12 ligands following tibial nerve injury in rats. J Reconstr Microsurg, 16: 613-620.
6. BIANCO JI, PERRY C, HARKIN DG, et al. (2004). Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose. Glia, 45: 111-123.
7. BUTOVSKY O, LANDA G, KUNIS G, et al. (2006). Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest, 116: 905-915.
8. CAYRE M, BANCILA M, VIRARD I, et al. (2006). Migrating and myelinating potential of subventricular zone neural progenitor cells in white matter tracts of the adult rodent brain. Mol Cell Neurosci, 31: 748-758.
9. CHEN GF, GU LQ, PEI GX. (2002). Peripheral nerve regeneration under immunosuppression. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 16: 139-141.
10. CHUAH MI, AU C. (1991). Olfactory Schwann cells are derived from precursor cells in the olfactory epithelium. J Neurosci Res, 29: 172-180.
11. CHUAH MI, WEST AK. (2002). Cellular and molecular biology of ensheathing cells. Microsc Res Tech, 58: 216-227.
12. CIZKOVA D, ROSOCHA J, VANICKY I, et al. (2006). Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol, 26: 1167-1180.
13. CURTIS MA, PENNEY EB, PEARSON AG, et al. (2003). Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci USA, 100: 9023-9027.
14. DENG J, PETERSEN BE, STEINDLER DA, et al. (2006). Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells, 24: 1054-1064.
15. DOBKIN BH, CURT A, GUEST J. (2006). Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair, 20: 5-13.
16. DOUCETTE JR. (1984). The glial cells in the nerve fiber layer of the rat olfactory bulb. Anat Rec, 210: 385-391.
17. DOUCETTE R. (1990). Glial influences on axonal growth in the primary olfactory system. GLIA, 3: 433-449.
18. DUBERNARD JM, OWEN E, HERZBERG G, et al. (1999). The first transplantation of a hand in humans. Early results. Chirurgie, 124: 358-365 ; discussion 365-7.
19. FÉRON F, PERRY C, COCHRANE J, et al. (2005). Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain, 128 (Pt 12): 2951-2960.
20. FÉRON F, PERRY C, MCGRATH JJ, et al. (1998). New techniques for biopsy and culture of human olfactory epithelial neurons. Arch Otolaryngol Head Neck Surg, 124: 861-866.
21. FRANKLIN RJ, GILSON JM, FRANCESCHINI IA, et al. (1996). Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS. Glia, 17: 217-224.
22. FREED CR, GREENE PE, BREEZE RE, et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med, 344: 710-719.
23. FURTADO S, SOSSI V, HAUSER RA, et al. (2005). Positron emission tomography after fetal transplantation in Huntington's disease. Ann Neurol, 58: 331-337.
24. FURUICHI Y, NOTO T, Li Y, et al. (2004). Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Res, 1014: 120-130.
25. GOLD BG, DENSMORE V, SHOU W, et al. (1999). Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther, 289: 1202-1210.
26. HAUBEN E, BUTOVSKY O, NEVO U, et al. (2000). Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci, 20 (17) : 6421-6430.
27. HAUSER RA, FURTADO S, CIMINO CR, et al. (2002). Bilateral human fetal striatal transplantation in Huntington's disease. Neurology, 58: 687-695.
28. HOGLINGER GU, RIZK P, MURIEL MP, et al. (2004). Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci, 7: 726-735.
29. HUANG H, CHEN L, WANG H, et al. (2006a). Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 20: 439-443.
30. HUANG H, CHEN L, WANG H, et al. (2003). Influence of patients'age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl), 116: 1488-1491.
31. HUANG H, WANG H, CHEN L, et al. (2006b). Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 20: 434-438.
32. IBRAHIM A, LI Y, LI D, et al. (2006). Olfactory ensheathing cells: ripples of an incoming tide? Lancet Neurol, 5: 453-457.
33. IMAIZUMI T, LANKFORD KL, BURTON WV, et al. (2000a). Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nat Biotechnol, 18: 949-953.
34. IMAIZUMI T, LANKFORD KL, KOCSIS JD. (2000b). Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res, 854: 70-78.
35. IMAIZUMI T, LANKFORD KL, WAXMAN SG, et al. (1998). Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci, 18: 6176-6185.
36. JIN K, GALVAN V, XIE L, et al. (2004). Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci USA, 101: 13363-13367.
37. KATO T, HONMOU O, UEDE T, et al. (2000). Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia, 30: 209-218.
38. KNOLLER N, AUERBACH G, FULGA V, et al. (2005). Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine, 3: 173-181.
39. KOSHIZUKA S, OKADA S, OKAWA A, et al. (2004). Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol, 63: 64-72.
40. LEE J, KURODA S, SHICHINOHE H, et al. (2003). Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology, 23: 169-180.
41. LENNINGTON JB, YANG Z, CONOVER JC, et al. (2003). Neural stem cells and the regulation of adult neurogenesis. Reprod Biol Endocrinol, 1: 99.
42. LI Y, FIELD PM, RAISEMAN G. (1997). Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science, 277: 2000-2002.
43. LI Y, FIELD PM, RAISEMAN G. (1998). Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci, 18 : 10514-10524.
44. LI Y, SAUVE Y, LI D et al. (2003). Transplanted olfactory ensheathing cells promote regeneration of cut adult rat optic nerve axons. J Neurosci, 23: 7783-7788.
45. LIMA C, PRATAS-VITAL J, ESCADA P, et al. (2006). Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med, 29: 191-203 ; discussion 204-206.
46. LOPEZ-VALES R, GARCIA-ALIAS G, FORÉS J, et al. (2005). FK 506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J Neurosci Res, 81: 827-836.
47. LU J, FÉRON F, HO SM, et al. (2001). Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res, 889: 344-357.
48. LU J, FÉRON F, MACKAY-SIM A, et al. (2002). Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain, 125: 14-21.
49. MACKINNON SE, DOOLABH VB, NOVACK CB, et al. (2001). Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg, 107: 1419-1429.
50. MARTIN D, PINSOLLE V, MERVILLE P, et al. (2005). First case in the world of autoreplantation of a limb associated with oral administration of an immunosupressant agent (FK 506-Tacrolimus). Ann Chir Plast Esthet, 50: 257-263.
51. MAZZINI L, MARESCHI K, FERRERO I, et al. (2006). Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res, 28: 523-526.
52. MIKAMI Y, OKANO H, SAKAGUCHI M, et al. (2004). Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. J Neurosci Res, 76: 453-465.
53. MYCKATYN TM, ELLIS RA, GRAN AG, et al. (2002). The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast Reconstr Surg, 109: 2405-2417.
54. NEUMANN H, WEKERLE H. (1998). Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol, 57: 1-9.
55. NISHIMURA T, IMAI H, MINABE Y, et al. (2006). Beneficial effects of FK506 for experimental temporal lobe epilepsy. Neurosci Res, 56: 386-390.
56. OLANOW CW, GOETZ CG, KORDOWER JH, et al. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol, 54: 403-414.
57. PARDO R, COLIN E, RÉGULIER E, et al. (2006). Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci, 26: 1635-1645.
58. PARENT JM, VON DEM BUSSCHE N, LOWENSTEIN DH. (2006). Prolonged seizures recruit caudal subventricular zone glial progenitors into the injured hippocampus. Hippocampus, 16: 321-328.
59. PASCUAL JI, GUDINO-CABRERA G, INSAUSTI R, et al. (2002). Spinal implants of olfactory ensheathing cells promote axon regeneration and bladder activity after bilateral lumbosacral dorsal rhizotomy in the adult rat. J Urol, 167: 1522-1526.
60. PHINNEY DG, ISAKOVA I. (2005). Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des, 11: 1255-1265.
61. PLUCHINO S, QUATTRINI A, BRAMBILLA E, et al. (2003). Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature, 422: 688-694.
62. PLUCHINO S, ZANOTTI L, ROSSI B, et al. (2005). Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature, 436: 266-271.
63. RAMON-CUETO A, CORDERO MI, SANTOS-BENITO FF, et al. (2000). Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron, 25: 425-435.
64. RAMON-CUETO A, NIETO-SAMPEDRO M. (1994). Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp Neurol, 127: 232-244.
65. RAMON-CUETO A, PLANT GW, AVILA J, et al. (1998). Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci, 18: 3803-3815.
66. RAMON-CUETO A, VALVERDE F. (1995). Olfactory bulb ensheathing glia: a unique cell type with axonal growth-promoting properties. Glia, 14: 163-173.
67. RAPALINO O, LAZAROV-SPIEGLER O, AGRANOV E, et al. (1998). Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med, 4: 814-821.
68. SAGHATELYAN A, DE CHEVIGNY A, SCHACHNER M, et al. (2004). Tenascin-R mediates activity-dependent recruitment of neuroblasts in the adult mouse forebrain. Nat Neurosci, 7: 347-356.
69. SASAKI M, HONMOU O, AKIYAMA Y, et al. (2001). Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia, 35: 26-34.
70. STEINER JP, HAMILTON GS, ROSS DT, et al. (1997). Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA, 94: 2019-2024.
71. SULAIMAN OA, VODA J, GOLD BG, et al. (2002). FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic schwann cell denervation. Exp Neurol, 175: 127-137.
72. SYKOVÁ E, JENDELOVÁ P, et al. (2004). Bone marrow stromal cells - a promising tool for therapy of brain and spinal cord injury. Exp Neurol, 187: 220.
73. TRELOAR HB, BARTOLOMEI JC, LIPSCOMB BW, et al. (2001). Mechanisms of axonal plasticity: lessons from the olfactory pathway. Neuroscientist, 7: 55-63.
74. UDINA E, CEBALLOS D, GOLD BG, et al. (2003). FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp Neurol, 183: 220-231.
75. URDZIKOVA L, JENDELOVA P, GLOGAROVA K, et al. (2006). Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma, 23: 1379-1391.
76. VATS A, BIELBY RC, TOLLEY NS, et al. (2005). Stem cells. Lancet, 366: 592-602.
77. VERDU E, NAVARRO X, GUDINO-CABRERA G, et al. (1999). Olfactory bulb ensheathing cells enhance peripheral nerve regeneration. Neuroreport, 10: 1097-1101.
78. WANG MS, ZELENY-POOLEY M, Gold BG. (1997). Comparative dosedependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J Pharmacol Exp Ther, 282: 1084-1093.
79. YAN J, XU L, CHEN D, et al. (2006). Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells, 24: 1976-1985.
80. ZAPPIA E, CASAZZA S, PEDEMONTE E, et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106: 1755-1761.
81. ZHANG J, LI Y, CHEN J, et al. (2005). Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol, 195: 16-26.
82. ZURITA M, VAQUERO J. (2006). Bone marrow stromal cells can achieve cure of chronic paraplegic rats: Functional and morphological outcome one year after transplantation. Neurosci Lett, 402: 51-56.